1 asset in Hemolytic Anemia
Therapeutic assets addressing Hemolytic Anemia, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Mitapivat Hemolytic Anemia | National Heart, Lung, and Blood Institute (NHLBI) | P1/2 | CCC (48) |